Ataseven B - Search Results

1

Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.

Prader S, Vollmar N, du Bois A, Heitz F, Schneider S, Ataseven B, Bommert M, Waltering KU, Heikaus S, Koch JA, Alesina PF, Traut A, Harter P. Prader S, et al. Among authors: ataseven b. Gynecol Oncol. 2019 Jan;152(1):76-81. doi: 10.1016/j.ygyno.2018.11.001. Epub 2018 Nov 18. Gynecol Oncol. 2019. PMID: 30463683

2

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.

Loibl S, Müller BM, von Minckwitz G, Schwabe M, Roller M, Darb-Esfahani S, Ataseven B, du Bois A, Fissler-Eckhoff A, Gerber B, Kulmer U, Alles JU, Mehta K, Denkert C. Loibl S, et al. Among authors: ataseven b. Breast Cancer Res Treat. 2011 Nov;130(2):477-87. doi: 10.1007/s10549-011-1715-8. Epub 2011 Aug 12. Breast Cancer Res Treat. 2011. PMID: 21837479

3

Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.

Ataseven B, Lederer B, Blohmer JU, Denkert C, Gerber B, Heil J, Kühn T, Kümmel S, Rezai M, Loibl S, von Minckwitz G. Ataseven B, et al. Ann Surg Oncol. 2015 Apr;22(4):1118-27. doi: 10.1245/s10434-014-4122-7. Epub 2014 Oct 9. Ann Surg Oncol. 2015. PMID: 25297900 Clinical Trial.

4

Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.

Ataseven B, Grimm C, Harter P, Prader S, Traut A, Heitz F, du Bois A. Ataseven B, et al. Gynecol Oncol. 2014 Dec;135(3):435-40. doi: 10.1016/j.ygyno.2014.10.003. Epub 2014 Oct 12. Gynecol Oncol. 2014. PMID: 25312398

5

Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.

Ataseven B, Kümmel S, Weikel W, Heitz F, Holtschmidt J, Lorenz-Salehi F, Kümmel A, Traut A, Blohmer J, Harter P, du Bois A. Ataseven B, et al. Arch Gynecol Obstet. 2015 May;291(5):1153-66. doi: 10.1007/s00404-014-3528-6. Epub 2014 Nov 5. Arch Gynecol Obstet. 2015. PMID: 25367604

6

Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery.

Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, Prader S, Polterauer S, Harter P, Grimm C. Ataseven B, et al. Gynecol Oncol. 2015 Sep;138(3):560-5. doi: 10.1016/j.ygyno.2015.07.005. Epub 2015 Jul 8. Gynecol Oncol. 2015. PMID: 26163893

7

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.

Kümmel A, Kümmel S, Barinoff J, Heitz F, Holtschmidt J, Weikel W, Lorenz-Salehi F, du Bois A, Harter P, Traut A, Blohmer JU, Ataseven B. Kümmel A, et al. Among authors: ataseven b. Geburtshilfe Frauenheilkd. 2015 Jul;75(7):710-718. doi: 10.1055/s-0035-1546050. Geburtshilfe Frauenheilkd. 2015. PMID: 26257408 Free PMC article.

8

Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV.

Ataseven B, Grimm C, Harter P, Heitz F, Traut A, Prader S, du Bois A. Ataseven B, et al. Gynecol Oncol. 2016 Feb;140(2):215-20. doi: 10.1016/j.ygyno.2015.12.007. Epub 2015 Dec 12. Gynecol Oncol. 2016. PMID: 26691222

9

Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.

Prader S, Harter P, Grimm C, Traut A, Waltering KU, Alesina PF, Heikaus S, Ataseven B, Heitz F, Schneider S, du Bois A. Prader S, et al. Among authors: ataseven b. Gynecol Oncol. 2016 May;141(2):271-275. doi: 10.1016/j.ygyno.2016.03.012. Epub 2016 Mar 17. Gynecol Oncol. 2016. PMID: 26972337

10

Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery.

Heitz F, Harter P, Alesina PF, Walz MK, Lorenz D, Groeben H, Heikaus S, Fisseler-Eckhoff A, Schneider S, Ataseven B, Kurzeder C, Prader S, Beutel B, Traut A, du Bois A. Heitz F, et al. Among authors: ataseven b. Gynecol Oncol. 2016 May;141(2):264-270. doi: 10.1016/j.ygyno.2016.03.015. Epub 2016 Mar 24. Gynecol Oncol. 2016. PMID: 26975900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page